Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (161-170 of 797) with videos related to

Pageof 80
Sort By:
The American Journal of Cardiology|December 21, 1984
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarctionJ T Willerson, L M Buja
Progress in Cardiovascular Diseases|January 1, 1987
Infarct size--can it be measured or modified in humans?L M Buja, J T Willerson
Postgraduate Medicine|February 29, 1988
Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarctionJ T Willerson, L M Buja
Postgraduate Medicine|February 29, 1988
Myocardial cellular alterations during myocardial ischemia and evolving infarctionJ T Willerson, L M Buja
Texas Heart Institute Journal|June 13, 2014
In memoriam: Mavis P. Kelsey, Sr. (1912-2013)Denton A Cooley, James T Willerson
Circulation|January 27, 1998
Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formationV Fuster, M Poon, J T Willerson
Texas Heart Institute Journal|March 5, 2010
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureMohammad Madjid, Muzammil Ali, James T Willerson
Circulation Research|September 18, 2012
Heparin and bone marrow-derived cell therapy: friend or foe?Edward T H Yeh, James T Willerson
Circulation|July 10, 2002
Cyclooxygenase-2 inhibition and cardiovascular eventsBertram Pitt, Carl Pepine, James T Willerson
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 25, 2002
How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevancePaolo Golino, Filippo Crea, James T Willerson
Pageof 80

Showing results (161-170 of 797) with videos related to

Sort By:
Pageof 80
The American Journal of Cardiology|December 21, 1984
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarctionJ T Willerson, L M Buja
Progress in Cardiovascular Diseases|January 1, 1987
Infarct size--can it be measured or modified in humans?L M Buja, J T Willerson
Postgraduate Medicine|February 29, 1988
Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarctionJ T Willerson, L M Buja
Postgraduate Medicine|February 29, 1988
Myocardial cellular alterations during myocardial ischemia and evolving infarctionJ T Willerson, L M Buja
Texas Heart Institute Journal|June 13, 2014
In memoriam: Mavis P. Kelsey, Sr. (1912-2013)Denton A Cooley, James T Willerson
Circulation|January 27, 1998
Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formationV Fuster, M Poon, J T Willerson
Texas Heart Institute Journal|March 5, 2010
Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureMohammad Madjid, Muzammil Ali, James T Willerson
Circulation Research|September 18, 2012
Heparin and bone marrow-derived cell therapy: friend or foe?Edward T H Yeh, James T Willerson
Circulation|July 10, 2002
Cyclooxygenase-2 inhibition and cardiovascular eventsBertram Pitt, Carl Pepine, James T Willerson
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 25, 2002
How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevancePaolo Golino, Filippo Crea, James T Willerson
Pageof 80